N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status.
In comparison to the general population, individuals with diabetes suffer a 3- to 4-fold increased risk for developing complications of atherosclerosis and vascular insufficiency. This fact should be taken into account to develop a suitable determinant for the early detection of these complications...
Main Authors: | Ahmed, K.A., Muniandy, S., Ismail, I.S. |
---|---|
Format: | Article |
Published: |
The Society for Free Radical Research Japan
2009
|
Subjects: |
Similar Items
-
Nε-(carboxymethyl) lysine and corony atherosclerosis-associated low density lipoprotein abnormalities in type 2 diabetes: current status
by: Ismail, I.S., et al.
Published: (2009) -
Implications of Nε-(Carboxymethy)lysine in altered metabolism of low density lipoproteins in patients with type 2 diabetes and coronary artery disease
by: Ahmed, K.A.A., et al.
Published: (2008) -
Evaluation of Nε-(carboxymethyl)lysine and lipid peroxidation in multiethnic Malaysian subjects with type 2 diabetes mellitus
by: Ismail, I.S., et al.
Published: (2011) -
Role of Nε-(Carboxymethyl)Lysine in the Development of Ischemic Heart Disease in Type 2 Diabetes Mellitus
by: Ahmed, Khaled A., et al.
Published: (2007) -
Immunohistochemical study of N-epsilon-carboxymethyl lysine (CML) in human brain: relation to vascular dementia
by: Southern, L, et al.
Published: (2007)